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Abstract. We have examined the role of two mesen- 
chymal ligands of epithelial tyrosine kinase receptors in 
mouse mammary gland morphogenesis. In organ cul- 
tures of mammary glands, hepatocyte growth factor 
(HGF, scatter factor) promoted branching of the ductal 
trees but inhibited the production of secretory proteins. 
Neuregulin (NRG, neu differentiation factor) stimu- 
lated lobulo-alveolar budding and the production of 
milk proteins. These functional effects are paralleled by 
the expression of the two factors in vivo: HGF is pro- 
duced in mesenchymal cells during ductal branching in 
the virgin animal; NRG is expressed in the mesen- 
chyme during lobulo-alveolar development a  preg- 
nancy. The receptors of HGF and NRG (c-met, c-erbB3, 
and c-erbB4), which are expressed in the epithelial 
cells, are not regulated. In organ culture, branching 
morphogenesis and lobulo-alveolar differentiation f 
the mammary gland could be abolished by blocking ex- 
pression of endogenous HGF and NRG by the respec- 
tive antisense oligonucleotides; in antisense oligonucle- 
otide-treated glands, morphogenesis could again be 
induced by the addition of recombinant HGF and 
NRG. We thus show that two major postnatal rnorpho- 
genic periods of mammary gland development are de- 
pendent on sequential mesenchymal-epithelial interac- 
tions mediated by HGF and NRG. 
ROWTH and morphogenesis of epithelia represent 
essential steps in the development of many eu- 
karyotic organs. A series of developmental studies 
have demonstrated that growth and morphogenesis of epi- 
thelia are closely regulated by mesenchymal-epithelial in- 
teractions. These studies include transplantation a d or- 
gan culture xperiments, which have been carried out with 
various systems uch as the salivary gland, the lung, the 
kidney, or the breast (Grobstein, 1953; Spooner and Wes- 
sells, 1970; Sax6n, 1987; Sakakura, 1991). The signaling 
molecules involved in mesenchymal-epithelial interactions 
during development are still largely unknown. Recent evi- 
dence suggests, however, that epithelial tyrosine kinase re- 
ceptors and their mesenchymal ligands can take over these 
functions (see Birchmeier and Birchmeier, 1993; for a re- 
view). 
Several tyrosine kinase receptors with prevalent expres- 
sion on epithelial cells have recently been characterized. 
The corresponding li ands are frequently synthesized by 
mesenchymal ce ls, i.e., could function in a paracrine man- 
ner (Stoker et al., 1987; Miki et al., 1991; Sonnenberg et 
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al., 1991, 1993; Peles et al., 1992; Weidner et al., 1993; Schu- 
chardt et al., 1994). Since certain tyrosine kinase receptors 
were first discovered because of their transforming poten- 
tial when mutated, they have commonly been associated 
with mediating mitogenic signals. However, it has recently 
become evident hat tyrosine kinase receptors can also 
regulate differentiation, cell movement, or morphogene- 
sis, i.e., these receptors and their ligands may direct deci- 
sive events in epithelial development (see Birchmeier and 
Birchmeier, 1993). For instance, hepatocyte growth factor 
(HGF) 1 has been shown to induce branching morphogene- 
sis of kidney epithelial cells in vitro (Montesano et al., 
1991). Cell biological and developmental studies have in- 
dicated that HGF is synthesized by mesenchymal (and 
neuronal) cells whereas its receptor, the tyrosine kinase 
c-met, is located in cells that potentially interact with mes- 
enchymal cells, e.g., epithelial cells (Stoker et al., 1987; 
Sonnenberg etal., 1993). Similarly, neuregulin (NRG) has 
been reported to affect growth and differentiation f epi- 
thelial (carcinoma) cells and is expressed inembryonic mes- 
enchyme and neuronal cells (Peles et al., 1992; Meyer and 
Birchmeier, 1994). Thus, HGF or NRG and the correspond- 
ing receptors represent ligand-receptor pairs that could me- 
1. Abbreviations used in this paper: ECM, extracellular matrix; HGF, 
hepatocyte growth factor; NRG, neuregulin; WAP, whey acidic protein. 
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diate important mesenchymal-epithelial interactions invivo. 
The importance of tyrosine kinase receptors in mesen- 
chymal-epithelial nteractions during development of kid- 
ney, lung, and liver has recently been supported by genetic 
experiments. A targeted mutation was introduced into the 
murine c-ret gene, which is expressed during embryogene- 
sis at the tips of the branching ureter buds in the kidney. 
Animals carrying two mutant alleles show severe hypopla- 
sia or aplasia of the kidneys (Schuchardt et al., 1994). The 
ligand for c-ret is as yet unknown, but was suggested to de- 
rive from the mesenchyme. A dominant-negative kerati- 
nocyte growth factor receptor under the control of a lung 
surfactant promoter was used to target expression to the 
embryonal lung buds in transgenic mice. Newborn mice 
that carry this transgene show severe defects in lung devel- 
opment, i.e., branching morphogenesis and differentiation 
of the lung epithelium is completely abolished (Peters et 
al., 1994). Furthermore, a targeted mutation of the HGF 
gene in mice led to embryonal lethality caused by severe 
liver and placenta defects (Schmidt et al., 1995; Uehara et 
al., 1995). The development of both these organs is regu- 
lated by mesenchymal-epithelial interactions. 
To study molecular aspects of mesenchymal-epitheliaI 
interactions, we used the mammary gland of female mice 
as an experimental system. The mammary gland is one of 
the few mammalian organs that undergoes major morpho- 
logical and functional changes after birth (for reviews ee 
Daniel and Silberstein, 1987; Sakakura, 1991). At birth, a 
primitive epithelial duct with few side-branches exists, 
which is embedded in the mesenchymal fat pad. During 
puberty, rapid elongation and branching of this primary 
epithelium proceeds until the ductal tree reaches the bor- 
der of the fat pad at 12 wk. At pregnancy, a second mor- 
phogenic phase begins with the budding of multiple alveoli 
from the ducts, which are assembled into lobules. These 
lobulo-alveolar structures are the functional units of milk 
production at lactation. After weaning, the glands undergo 
massive remodeling, which results in the regression of the 
lobulo-alveolar structures and the return to the stage of 
the ductal tree. Branching morphogenesis and lobulo-alve- 
olar differentiation of the mammary gland are regulated 
by a complex interplay of systemic hormonal signals and 
local factors (for reviews ee Daniel and Silberstein, 1987; 
Imagawa et al., 1990). In these processes, mesenchymal- 
epithelial as well as epithelial-mesenchymal interactions 
between the cells of the fat pad and of the ducts and alve- 
oli play a role (DeOme et al., 1958; for review see 
Sakakura, 1991). Three modes of signal transduction be- 
tween mesenchyme and epithelium have been suggested: 
(a) interactions mediated by direct cell-cell contact; (b) in- 
teractions mediated by the extracellular matrix; and (c) 
diffusion of soluble factors (Levine and Stockdale, 1985; 
Sakakura, 1991; Howlett and Bissell, 1993). The identity of 
soluble factors involved in mesenchymaI-epithelial inter- 
actions during mammary gland development were previ- 
ously not known. 
We have here identified two mesenchymal factors, 
hepatocyte growth factor and neuregulin, that play impor- 
tant roles in the development of the mammary epithelium. 
HGF, which is identical to scatter factor, is the prototype 
of an emerging family of motility and growth factors that 
resemble in their domain structure and mechanism of acti- 
vation the blood proteinase plasminogen (Miyazawa et al., 
1989; Nakamura et al., 1989; Weidner et al., 1991; Hart- 
mann et al., 1992). The pleiotropic responses of HGF on 
cells are mediated by the receptor tyrosine kinase c-met 
(Bottaro et al., 1991; Naldini et al., 1991; Weidner et al., 
1993). During mouse embryogenesis, various epithelia 
that form branching tubular structures, i.e., the lung, pan- 
creas, or salivary gland, express c-met, while the surround- 
ing mesenchyme produces HGF (Sonnenberg etal., 1993). 
Neuregulin, also called neu differentiation factor, heregu- 
lin, ARIA, glial growth factor, is a novel factor that has 
several functions on diverse cell types in culture: (a) induc- 
tion of growth and differentiation of mammary carcinoma 
cells; (b) induction of growth of glial cells and glial cell fate 
from neuronal precursor cells; and (c) induction of termi- 
nal differentiation of myotubes (Holmes et al., 1992; Peles 
et al., 1992; Falls et al., 1993; Marchionni et al., 1993; Shah 
et al., 1994). Various transcript isoforms (c~-, 13-, and iso- 
forms containing a kringle-like domain) are all derived 
from one NRG gene by alternative splicing and probably, 
the use of two promoters (Falls et al., 1993; Marchionni et 
al., 1993; Peles and Yarden, 1993; Wen et al., 1994). An 
epidermal growth factor (EGF)-like motif was found to 
act as the essential functional domain in all NRG isoforms. 
Recently, it was shown that the interaction of NRG with 
the target cells is mediated by c-erb B4, which binds NRG 
directly and with high affinity (Plowman et al., 1993). Fur- 
thermore, c-erb B3 can act, alone or in combination with 
c-erbB2/neu or c-erb B4, as a further receptor for NRG 
(Sliwkowski et al., 1994; Carraway and Cantley, 1994). 
NRG is expressed in various neuronal and mesenchymal 
tissues during mouse embryogenesis (Orr Urtreger et al., 
1993; Meyer and Birchmeier, 1994), while c-erbB3 and 
c-erbB4 are frequently found in cells that interact with 
neuronal or mesenchymal cells such as glia, muscle, or epi- 
thelial cells (Kraus et al., 1989; Press et al., 1990; Prigent et 
al., 1992; Plowman et al., 1993). 
Materials and Methods 
Mammary Gland Organ Culture 
Whole mammary glands of hormonally primed mice were cultured in se- 
rum-free medium according to Banerjee et al. (1976): 4-wk-otd BALB/c 
mice were injected subcutaneously for nine consecutive days with 1 mg 
progesterone and 1 ~g estradiol (Sigma Chemical Co., St. Louis, MO) dis- 
solved in gummi arabicum/0.9% NaCl. The second pair of thoracic glands 
was excised and cultivated for 5 d on cyclopore membranes (Falcon Plas- 
tics, Cockeysville, MD) in 2 ml medium 199 with Hanks' salts (GIBCO 
BRL, Gaithersburg, MD), gentamycin (40 ixg/ml), aldosterone, bovine 
prolactin, insulin (each at 5 ixg/ml; Sigma), and hydrocortisone (1 ixglml; 
Merck, Darmstadt, Germany) (referred to as "APIH standard medium"). 
For experiments with NRG, prolactin concentration was reduced to 3 txg/ 
ml (modified APIH medium). Medium was changed every 2 d. Three 
pairs of contralateral glands were routinely examined, one member of 
each pair was the test sample, the other the control. Formalin-fixed whole 
glands were stained with hematoxylin as described (Rivera, 1971). Stained 
glands were also embedded in paraffin, cut at 5 txm, and stained with he- 
matoxylin/eosin. For the analysis of milk production, 500 alveolar struc- 
tures on paraffine sections were examined in each experimental group for 
the presence of luminal secretory products and intraepithelial fat droplets 
(counted positive when >50% of epithelial cells contained roplets). 
The 17 mer phosphorothioate oligonucleotides u ed in the organ cul- 
ture were synthesized and purified by high-performance liquid chroma- 
tography (BioTez Berlin-Buch GmbH). Sequences were taken from the 
mouse HGF and NRG cDNAs, respectively, beginning with the transla- 
tion start (Sonnenberg etal., 1993; Meyer and Birchmeier, 1994): HGF an- 
The Journal of Cell Biology, Volume 131, 1995 216 
tisense, 5'-TI'GGTCCCCCACATCAT-3'; sense, 5'-ATGATGTGGGGG- 
ACCAA-3'; NRG antisense, 5'-TCTTTGCGCTCAGACAT-3',  sense, 
5 ' -ATGTCTGAGCGCAAAGA-3' .  The oligonucleotides were added to 
the medium at day 1 of the culture period and supplied with each medium 
change. 
Recombinant HGF and NRG 
Recombinant HGF was produced in Sf9 insect cells by means of the bacu- 
lovirus expression system as described (Weidner et al., 1993). In selected 
experiments, we also used the a[3-heterodimeric form of HGF cleaved by 
urokinase-Sepharose (Higgins and Vehar, 1987; Naldini et al., 1992). The 
EGF-like domain of the 13-isoform of NRG was prepared as described 
(Holmes et al. 1992; Meyer and Birchmeier, 1993). Alternatively, a 132a- 
subform of NRG was produced by the baculovirus expression system. The 
coding sequence (amino acids 20-239, Wen et al., 1994) was fused in 
frame to the signal sequence of expression vector pAcGP67 (Dianova, 
Hamburg, Germany). NRGI32a was purified on heparin-Sepharose using a 
NaC1 gradient. 
Expression Analyses 
The second pairs of thoracic mammary glands from virgin, primiparous 
pregnant, lactating, or involuting BALB/c mice were prepared and snap 
frozen in liquid nitrogen. Total RNA was isolated according to Chom- 
czynski and Sacchi (1987). RNase protection was performed as described 
by Birchmeier et al. (1987). Probes were synthesized as run-off transcripts 
from the corresponding cDNAs in the pBluescript vector with T7 RNA 
polymerase using [a32p]UTP (specific activity of 3,000 Ci/mmol; NEN Du- 
Pont). The probes were (a) mHGF1, a 449-nt ranscript containing 126 nt 
of the murine HGF cDNA in antisense orientation (positions 467-593); 
(b) mMetl,  a 471 nt transcript containing 137 nts of the murine c-met 
cDNA in antisense orientation (positions 3867--4004) and 334 nts of the 
plasmid derived sequence (Sonnenberg et al., 1993); (c) pNN, a 390-nt 
transcript composed of 290 nts of the murine NRG cDNA in antisense ori- 
entation (positions 391~581 of the cDNA sequence) and additional 100 nts 
from the plasmid-derived sequence; (d) pNa, a 346-nt ranscript contain- 
ing 259 nts of the murine NRG cDNA in antisense orientation (positions 
899-1158 in the rat cDNA sequence) and additional 87 nts from the plas- 
mid sequence (Meyer and Birchmeier, 1994); and (e) p-erb B4, a 223-nt 
transcript containing 141 nts of the murine c-erb B4 cDNA in antisense 
orientation (corresponding to positions 2486-2627 in the human sequence, 
Plowman et al., 1993) and additional 82 nts of plasmid sequence. A 304-nt 
antisense transcript derived from the murine 13-actin cDNA containing 
250 nts of coding sequence, was used as a control. For detection of HGF 
and c-met mRNA fragments, 40 Ixg of total RNA were hybridized to the 
corresponding 32p-labeled transcripts (50,000 cpm of each probe). To ana- 
lyze NRG and c-erbB-4 mRNA, 35 gg and 100 Ixg of total RNA were hy- 
bridized, respectively. 
For in situ hybridization (Sonnenberg et al., 1991), cryostat sections of 
the second thoracic mouse mammary glands at various developmental 
stages were used. Antisense and sense RNA probes were synthesized 
from the cDNA fragments in the pBluescript vector with either T7 or T3 
RNA polymerase and 35S-labeled UTP and CTP (specific activities of 
>1,000 Ci/mmol). l0 s cpm of the labeled probes were used for hybridiza- 
tion. Probes were as follows: mHGF2, obtained from a murine HGF 
cDNA (positions 1104-2634); mMet2, obtained from murine c-met cDNA 
(positions 2298-3974); pN1, obtained from murine NRG cDNA (corre- 
sponding to positions 391-1458); murine p-erbB4, corresponds topositions 
834-2628. For Northern blot analysis, total RNA (15 ttg) was electro- 
phoresed in 1% agarose-formaldehyde gels, transferred toHybond C-extra 
membranes (Amersham International, Amersham, UK), and hybridized 
to 32p-labeled cDNA probes followed by autoradiography (Sambrook et 
al., 1989). Murine cDNA probes for [3-casein (Binas et al., 1992), whey 
acidic protein (WAP, a kind gift of Dr. Nancy Hynes, Friedrich-Miescher- 
Institut, Basel) and [3-actin were labeled by random priming (109 cpm/~Lg; 
Feinberg and Vogelstein, 1984). Hybridization signals were analyzed with 
a Phosphorlmager. 
Results 
Effects of HGF and NRG in Mammary Gland 
Organ Culture 
Mammary gland organ cultures were established from 
hormonally primed mice at the age of four weeks (see Ma- 
terials and Methods). At this stage, a sparsely developed 
epithelial tree with few end buds occupies ~40% of the 
mammary fat pad. Under optimal conditions for organ cul- 
ture, ductal branching and alveolar morphogenesis take 
place within the next week leading to a glandular tree with 
lobulo-alveolar structures and the synthesis of milk con- 
stituents (Fig. 1, a, c, and e). This organ culture system thus 
allows testing the effects of exogenous and endogenous 
modulators on the various developmental processes, both 
in terms of kinetics and end points. Since contralateral 
pairs of glands exhibit virtually identical patterns of epi- 
thelial morphogenesis, the effect of factors on one mem- 
ber of the paired glands can be easily compared to the un- 
treated control. 
In organ culture, treatment of glands in standard APIH 
(serum-free) medium with recombinant HGF (at 20 ng/ 
ml) for five days resulted in the appearance of unusually 
strongly branched glandular trees (compare Fig. 1, b and d 
with a and c). In the control, the primary ducts that origi- 
nate from the nipple have few small side branches (Fig. 1, 
a and c, arrows). In the presence of HGF, branching is 
strongly intensified resulting in numerous main ducts that 
elongate toward the border of the fat pad (Fig. 1, b and d, 
arrows). Morphometric analysis revealed an average of 
two main side branches (range 1-3) in the absence and 
side side branches (range 3-8) in the presence of HGF 
(seven pairs of glands were examined). Concomitantly, 
HGF inhibited the secretory activity of the epithelial cells 
(Fig. 1, e and f): 82 ___ 3% of the alveoli displayed secretory 
activity in the absence and 26 ± 2% in the presence of 
HGF (four pairs of glands were counted). Concentrations 
of HGF at 20 ng/ml were most effective for the stimulation 
of ductal branching; lower concentrations were less effec- 
tive, 100 ng/ml slightly inhibited development of the 
glands. 
In contrast, the addition of recombinant NRG to the 
culture medium for five days stimulated the production of 
lobulo-alveolar structures. This was particularly obvious at 
reduced prolactin concentration (i.e., in modified APIH 
medium), i.e., at conditions where differentiation is de- 
layed. In the control glands, only single alveoli developed 
(Fig. 2, a and c). In the presence of NRG (3 nM), the num- 
ber of alveoli was markedly increased and they were clus- 
tered into lobules (Fig. 2, b and d; arrows). Morphometric 
measurement (see Fig. 2 legend) revealed an average of 
three lobules per analyzed field (range 0-6) in the absence 
and 17 lobules (range 10-30) in the presence of NRG (five 
pairs of glands were examined). The concentration of 3 
nM was found to be optimal for both the soluble 13-form 
and the EGF-like domain of NRG. Histological analysis 
corroborated the more progressed lobular development in 
the presence of NRG and showed increased luminal pro- 
tein secretion and intracellular fat droplet accumulation: 
21 +-- 9% of the alveoli displayed secretory activity in the 
absence and 97 -+ 2% is the presence of NRG. Fat droplet- 
positive alveoli increased from 20 -+ 8% to 99% (seven 
pairs of glands were examined). 
We also analyzed in organ culture the effects of HGF 
and NRG on the expression of milk proteins [3-casein and 
WAP. HGF added to single members of paired glands in 
standard APIH medium markedly reduced 13-casein and 
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Figure 1. Effect of HGF on 
mammary gland morphol- 
ogy in organ culture. Whole 
mouse mammary glands 
were cultured for 5 d in 
APIH standard medium, (a, 
c, and e) in the absence or (b, 
d, and f) in the presence of 
20 ng/ml recombinant HGF. 
(a and b) Whole mount stain- 
ing with hematoxylin; pl and 
p2 indicate pairs of contralat- 
eral glands. (c and d) Higher 
magnification of the areas in- 
dicated in a and b by arrow- 
heads. (e and f) Histology of 
sections of cultured glands 
stained with hematoxylin/ 
eosin. Arrows indicate filled 
(e) or empty alveoli (f), re- 
spectively. Bars: (e and f) 100 
Ixm. Morphometry ofbranch- 
ing (see text) was performed 
in areas of newly formed 
structures (see Fig. 1, c and d). 
abolished WAP expression (Fig. 3 A, compare lanes 2 and 
4 with 3 and 5). In contrast, NRG (at reduced prolactin 
concentration, i.e., modified APIH medium) induced the 
expression of WAP and 13-casein (Fig. 3 B, compare lanes 
2 and 4 with 3 and 5). We also examined EGF for its effect 
in the organ culture system: EGF stimulated uctal prolif- 
eration but not branching. Furthermore, EGF inhibited al- 
veolar maturation and milk production (data not shown). 
Expression of HGF and NRG During Mammary Gland 
Development In Vivo 
To examine whether HGF and NRG could possibly have 
the suggested functions in vivo, we examined by RNase 
protection analysis the temporal and spatial expression 
pattern of the two factors during the various stages of 
mammary gland development. We found that HGF ex- 
pression is strongly regulated uring mammary gland de- 
velopment, reaching the highest level during ductal mor- 
phogenesis in the virgin animal (Fig. 4, A and B). 
Expression levels decrease during pregnancy and lactation 
and increase again during involution. Quantitative analysis 
showed that HGF expression at 12 wk is upregulated by 
approximately one order of magnitude in comparison to 
the lactation stage. A single fragment, 126 nucleotides in 
length, was observed in the RNase protection analysis, in- 
dicating that the splice variant encoding HGF with addi- 
tional five amino acids in kringle 1 (Weidner et al., 1991) is 
expressed in the mammary gland. In contrast, mRNA lev- 
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Figure 2. Effect of NRG on 
mammary gland morphol- 
ogy in organ culture. Mam- 
mary glands were cultured 
for 5 d in modified APIH 
medium, (a, c, and e) in the 
absence or (b, d, and f) the 
presence of 3 nM recombi- 
nant NRG. To decrease alve- 
olar development, he con- 
centration of prolactin in the 
medium was reduced to 3 ~g/ 
ml (modified APIH me- 
dium). (a and b) Whole 
mount staining; pl and p2 in- 
dicate pairs of contralateral 
glands. (c and d) Higher 
magnification of the areas in- 
dicated in a and b by arrow- 
heads demonstrates the in- 
creased ensity and thickness 
of lobular alveoli in the 
glands treated with NRG. (e 
and f) Histological analysis. 
Arrows indicate empty (e) 
and filled alveoli (f), respec- 
tively. Morphometry of lob- 
ule formation (see text) was 
performed in areas that were 
newly formed during organ 
culture (see field of Fig. 2, c 
and d). Bar, 100 p~m. 
els for the HGF receptor c-met (and for actin as a control) 
did not change significantly during mammary gland devel- 
opment. 
NRG showed a completely different but again strongly 
regulated expression pattern: the highest level of tran- 
script is observed during the process of lobulo-alveolar 
morphogenesis at pregnancy (Fig. 4, A and C). No NRG 
mRNA was measured uring the virginal period (except 
for a weak signal in the adult animal at 12 wk), and expres- 
sion again sharply decreased uring lactation and was ab- 
sent during involution. NRG expression at pregnancy was 
two orders of magnitude higher than in the adult stage. 
The presence of a protected band at 259 nt in length using 
probe pNct indicates that the ere-subtype of NRG (see Pe- 
les and Yarden, 1993; Meyer and Birchmeier, 1993) is ex- 
pressed during pregnancy; no protected fragment of 13 
variants (at 120 nt) was observed. RNase protection with 
probe pNN yielded no 240-nt fragment (as in brain, Fig. 4 
D) and therefore, subforms containing the kringle-like do- 
main are also not expressed in the mammary gland. The 
expression of the high affinity receptor of NRG was also 
examined; c-erbB4 is not expressed in the glands of prepu- 
bertal mice but is seen at approximately the same level in 
the virgin animals and in all further stages of development 
(Fig. 4 C). 
HGF and NRG expression during mammary gland de- 
velopment was also examined by in situ hybridization: in 
the adult gland, HGF transcripts are detected in a thin 
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Figure 3. Effect of HGF and NRG on the expression of milk pro- 
teins in organ culture. Theexpression of I3-casein and whey acidic 
protein (WAP) in two pairs ofcontralateral glands (one member 
of the pairs was treated, the other non-treated) was analyzed by 
Northern blotting. (A) Effect of 20 ng/ml HGF after 5 d of organ 
culture in standard APIH medium: (lanes 2 and 4) RNA from 
control glands; (lanes 3 and 5) RNA from treated contralateral 
glands. (B) Effect of 3 nM NRG after 5 d of organ culture in 
modified APIH medium (see legend to Fig. 2): (lanes 2 and 4)
RNA from control glands; (lanes 3 and 5) RNA from treated con- 
tralateral glands. (lane 1 in A and B) RNA from noncultivated 
glands. 
layer of mesenchymal cells adjacent o the ductal epithe- 
lium (Fig. 5 A, a). In contrast, he transcripts for the c-met 
receptor are localized within the basal epithelial cell layer 
of the ductal epithelium (Fig. 5 A, b). At pregnancy, NRG 
transcripts are widely detected in the connective tissue 
around both ductal and alveolar structures (Fig. 5 B, a and 
b). In contrast, the receptors c-erbB4 and c-erbB3 are ex- 
pressed in the epithelium (shown for c-erbB4 in Fig. 5 B, c). 
Effects of Treatment of Mammary Gland Organ 
Cultures with Antisense Oligonucleotides 
Evidence for an obligatory function of HGF and NRG 
during branching and lobulo-alveolar morphogenesis of
the mammary gland, respectively, is provided by interfer- 
ence with antisense phosphorothioate oligonucleotides. 
We first established the pattern of expression of both fac- 
tors during our standard organ culture: HGF mRNA is ex- 
pressed at the start of culture and slowly decreases, while 
NRG mRNA expression is initially absent but increases 
from day 3 on (data not shown, see also Fig. 6 A). Treat- 
ment of organ cultures with antisense HGF oligonucle- 
otide (see Materials and Methods) abolished the expres- 
sion of HGF mRNA, whereas ense oligonucleotide had 
no effect (Fig. 6 A, compare lanes 3 and 4). Treatment of 
glands with antisense NRG strongly reduced expression of 
NRG mRNA (Fig. 6 A, compare lanes 7 and 8). Micro- 
scopic inspection showed that antisense HGF oligonucle- 
otide blocked ductal branching of the glands (Fig. 6 B, b 
and d, arrows and arrowheads), while the sense oligonu- 
cleotide had no effect (Fig. 6 B, a and c). Antisense NRG 
oligonucleotide quenched lobulo-alveolar development to
a stage where mainly primary ducts are present (Fig. 6 B, f 
and h, arrowheads). Again, the corresponding sense oligo- 
nucleotide had no effect on lobulo-alveolar development 
(Fig. 6 B, e and g). NRG antisense oligonucleotide also 
markedly reduced milk protein expression (data not 
shown). Titration of biological activity of antisense oligo- 
nucleotides showed maximum effects at 10 (for HGF) and 
3 ~M (for NRG). 
We also demonstrate that the effects of treatment of 
mammary glands with antisense oligonucleotides were 
compensated by addition of appropriate xogenous fac- 
tors. Thus, HGF fully restores ductal branching in glands 
treated with HGF antisense oligonucleotides (Fig. 7 A, 
compare a and b). In the histological analysis, numerous 
developing side branches were seen after HGF treatment 
(arrows in Fig. 7 A, d, compare with the control in c). Sim- 
ilarly, exogenous NRG restores lobulo-alveolar develop- 
ment of the glands treated with NRG antisense oligonu- 
cleotide (Fig. 7 B, compare a and b). As shown by the 
histological analysis, antisense NRG oligonucleotide fully 
quenched alveolar budding; only intraductal precursors 
were present (Fig. 7 B, c, arrows). Addition of exogenous 
NRG overcame the effect of antisense oligonucleotide, 
i.e., fully supported budding and maturation (Fig. 7 B, d). 
Discussion 
We demonstrate here that two mesenchymal factors, 
hepatocyte growth factor and neuregulin, control morpho- 
genesis and differentiation f epithelia during mouse 
mammary gland development. In organ culture, exoge- 
nously added HGF induces intensive branching of mam- 
mary ducts, whereas exogenous NRG promotes the for- 
mation of lobular alveoli that is followed by terminal 
differentiation. The respective antisense oligonucleotides 
abolish morphogenesis and differentiation of the glands, 
apparently by interfering with expression of endogenous 
HGF and NRG. Furthermore, the in vivo expression of 
the two factors closely parallels their functional role, i.e., 
HGF is produced uring the ductal branching period in 
virgin mice, whereas NRG is strongly induced during lob- 
ulo-alveolar development a pregnancy. Thus, two essen- 
tial steps in mammary gland development can now be ex- 
plained on a molecular level: the specific morphogens 
HGF and NRG are induced in the mesenchyme of the 
gland and then affect he nearby epithelium. Apparently, 
the expression of HGF and NRG is under tight hormonal 
control. We also show that the epithelial tyrosine kinase 
receptor c-met and the corresponding c-erbB receptors 
are expressed at appropriate times during the develop- 
ment of the mammary gland and therefore likely represent 
critical components in the response to the mesenchymal 
signals. 
It has previously been found that HGF is an inducer of 
branching morphogenesis of MDCK (kidney) epithelial 
cells in collagen gels (Montesano et al., 1991). Similarly, 
HGF promoted the formation of branching duct-like 
structures of mammary gland and other epithelial cells in 
collagen gels (Soriano et al., 1995; V. Brinkmann and W. 
Birchmeier, manuscript submitted for publication). Dur- 
ing mouse embryogenesis, the HGF receptor c-met is ex- 
pressed in many tubular epithelia, for example, in branch- 
ing epithelia of kidney, lung, salivary glands, and pancreas 
(Sonnenberg et al., 1993). In contrast, HGF expression is
found in mesenchyme surrounding these tubular epithelia. 
HGF expression is also detected in primary fibroblasts i o- 
lated from human breasts, and c-met is located on ductal 
epithelial cells (Tsarfaty et al., 1992; Seslar et al., 1993). In 
the present study, we show that HGF is essential for induc- 
tion of branching of mammary ducts in organ culture 
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Figure 4. Differential expression 
of HGF and NRG during mammary 
gland development. (A) Quantita- 
tive patterns of expression levels for 
HGF (11) and the a2-subtype of 
NRG (A) were evaluated from the 
results of Fig. 4, B and C by phos- 
phoimage analysis. Radioactive 
counts are expressed as PSL. (B) 
RNase protection analysis of HGF 
and c-met expression during the de- 
velopment of mouse mammary 
glands. Total RNA of whole mam- 
mary glands from postnatal (2, 6, 
and 12 wk old), from pregnant (at 7 
and 15 d), and from lactating and 
involuting mice was subjected to 
RNase protection with a HGF tran- 
script probe (mHGF1), with a c-met 
probe (mMetl), or an actin control 
probe (see Materials and Methods). 
m, Markers (MspI-digested pBR 
322); t-RNA, control digest; input, 
nondigested probe. (C and D) 
RNase protection analysis of NRG 
and c-erb B4 expression in the 
mouse mammary gland. Total RNA 
from mammary glands of the differ- 
ent stages was subjected to RNase 
protection analysis using probe 
pNc~ for NRG and probe c-erbB4. 
In D probe pNN for NRG was used 
(see Meyer and Birchmeier, 1994). 
rn, Markers; tRNA, control digest; 
input, nondigested probe. 
(Figs. 1 d and 7 A). Specific antisense HGF oligonucle- 
otides fully prevented endogenous branching that could be 
overcome by the addition of exogenous factor. Further- 
more, HGF is expressed during virginhood exclusively in a 
thin layer of mesenchymal cells located around the ducts, 
whereas the c-met receptor is located in the basal ayer of 
epithelial cells. This indicates that HGF functions in para- 
crine manner and provides a molecular basis for the local 
interactions between mesenchymal and epithelial cells. In- 
terestingly, HGF in organ culture inhibited lobulo-alveo- 
lar development and milk production, indicating that 
branching morphogenesis must precede functional differ- 
entiation. This is in line with the fact that ductal growth in 
vivo occurs mainly during virginhood whereas functional 
differentiation is a subsequent event during pregnancy. 
It has previously been shown that NRG can induce 
growth and differentiation of epithelial cells in vitro, e.g., 
breast cancer cell lines respond with the production of 
milk proteins (Wen et al., 1992; Bacus et al., 1993; Culous- 
cou et al., 1993). NRG stimulated the expression of a 22- 
kD milk protein but inhibited DIP-induced expression of 
[3-casein in HCl l  mouse mammary epithelial cells (Marte 
et al., 1995). During embryogenesis of the mouse, a high 
concentration of NRG transcripts in the immediate vicin- 
ity of epithelia of many developing organs was observed 
(Meyer and Birchmeier, 1994). We demonstrate here that 
NRG plays an essential role during differentiation of 
mammary epithelia in vivo. In organ culture, NRG in- 
duces the production of alveoli that are assembled into 
lobules (Figs. 2 d and 7 B) and promotes the expression of 
milk proteins 13-casein and WAP. Furthermore, NRG ex- 
pression in the stroma of the mammary gland is strongly 
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Figure 5. Cellular localization f HGF, c-met, NRG, and c-erbB4 expression in themammary gland by in situ hybridization a d bright 
field illumination. Sections of mammary glands of 12 wk adult (A, a and b) and 15 d pregnant mice (B, a-c) were hybridized with e 
HGF antisense probe mHGF2 (A, a), with the c-met antisense probe mMet2 (A, b), with the NRG antisense probe pN1 (B, a nd b), or 
with the c-erbB4 antisense probe (B, c). Bars: (A, a and b) 20 Ixm; (B, a) 40 Ixm; (B, b and c) 20 txm. 
induced at pregnancy, i.e., at times when lobulo-alveolar 
structures develop; specific antisense oligonucleotides n- 
hibited lobule formation and production of milk proteins. 
We also show that an a-isoform of NRG, i.e., a mesenchy- 
mal form, is expressed uring mammary gland morpho- 
genesis. Thus, NRG is a further key player in the mesen- 
chymal-epithelial interactions of the mammary gland 
which, in comparison to HGF, produces a qualitatively dif- 
ferent response. Signal transduction by c-met and c-erbB 
receptors have recently been examined: HGF acts through 
a single receptor that activates characteristic downstream 
substrates (Hartmann et al., 1994; Ponzetto et al., 1994; 
Weidner et al., 1995). In contrast, NRG binding and signal 
transduction appears to involve complex hetero-oligomer- 
ization between three c-erbB receptors (Plowman et al., 
1993; Sliwkowski et al., 1994) and therefore, multiple sig- 
nal transduction pathways are involved (Ben Levy et al., 
1994; Carraway and Cantley, 1994; Prigent and Gullick, 
1994). Further understanding of the complex interplay of 
downstream targets of c-met and the c-erbBs is required to 
explain the different signaling capacities of the two recep- 
tor systems in mammary gland development. 
Morphogenesis and regression of the mammary gland is 
accompanied by extensive xtracellular matrix (ECM) re- 
modeling that is mediated by ECM-degrading proteases 
(Talhouk et al., 1991; Sympson et al., 1994). This is in line 
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Figure 6. Effect of HGF and NRG antisense oligonucleotides in mammary gland organ culture. Mammary glands were cultured in stan- 
dard APIH medium for 4 d (for HGF interference) and 6 d (for NRG interference) in the presence of the corresponding sense or anti- 
sense oligonucleotide phosphorothioates: (A) RNase protection a alysis of HGF (lanes 2--4) and NRG expression (lanes 6--8). (lanes 1 
and 5) Input band; (lanes 2 and 6) untreated gland; (lanes 3 and 7) sense oligonucleotide; (lanes 4 and 8) antisense oligonucleotide (10 
and 3 IxM for interference with HGF and NRG transcript formation, respectively), m, Marker. (B) Morphological evaluation of the ef-
fect of treatment with antisense oligonucleotides: (a and c) 10 ~xM HGF sense oligonucleotide; (b and d) 10 ~zM HGF antisense oligonu- 
cleotide; (e and g) 3 txM NRG sense oligonucleotide; ( land h) 3 IxM NRG antisense oligonucleotide, c, d, g, and h show higher magnifi- 
cations of the indicated areas in a, b, e, and f(see arrows). 
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Figure Z Restoration of branching morphogenesis and differentiation in antisense oligonacleotide-treated organ cultures by the addi- 
tion of exogenous HGF and NRG. (A) Paired glands were cultured for 4 d in the presence of 10 p~M HGF antisense oligonucleotide in 
the absence (a and c) and presence of 20 ng/ml exogenous HGF (b and d). Arrows in (d) indicate developing side branches. (B) Paired 
glands were cultured for 6 d in the presence of 3 ixM NRG antisense oligonucleotide in the absence (a and c) and presence of 3 nM NRG 
(b and d). Arrows in c indicate intraductal alveolar precursors. 
with the fact that HGF induces synthesis and secretion of 
proteases in epithelial cells (Pepper et al., 1992). Protease 
activities are also increased uring involution (Talhouk et 
al., 1992), i.e., at times when HGF is highly expressed. In 
cell culture of mammary epithelial cells, NRG induces the 
expression of cell adhesion molecules uch as ICAM-I and 
E-cadherin (Bacus et al., 1993; Staebler et al., 1994), which 
might be important for alveolar maturation and tissue-spe- 
cific gene regulation. Various growth factors uch as EGF, 
TGFa, and TGFI31 are suppressors of HGF expression of 
fibroblasts in cell culture (Gohda et al., 1992; Seslar et al., 
1993). These factors are produced in the epithelium of the 
mammary gland during postnatal development and influ- 
ence ductal and alveolar development mainly in an auto- 
crine manner (Vonderhaar, 1987; Coleman et al., 1988; 
Snedeker et al., 1991; Silberstein et al., 1992; Jhappan et 
al., 1993; Pierce et al., 1993; Spitzer et al., 1995). Other 
growth and differentiation factors are also expressed in 
the mammary gland, i.e., several members of the FGF and 
wnt families (Gavin and McMahon, 1992; Coleman- 
Krnacik and Rosen, 1994; Ulich et al., 1994). The regula- 
tion of HGF and NRG synthesis in the mesenchyme dur- 
ing postnatal mammary gland development is obviously 
under control of systemic hormones. Mammary stromal 
cells in fact respond to hormonal signals (Haslam and 
Counterman, 1991), and glucocorticoids downregulate 
HGF expression in cell culture (Gohda et al., 1992). In- 
creasing levels of glucocorticoids in the circulation might 
thus be responsible for decreasing HGF levels during 
pregnancy. In the mammary gland, reciprocal interactions 
of mesenchyme and epithelia are also apparent: our exper- 
iments show that mammary fat pads cleared of epithelia 
do not express HGF or NRG. The molecular nature of 
these epithelial signals is not yet known. 
In conclusion, morphogenesis and differentiation f the 
mammary gland is regulated by a complex interplay of sys- 
temic hormones and local factors: mesenchymal cells of 
the fat pad appear to respond to hormonal stimuli and 
then produce short-range signals that control growth, mor- 
phogenesis, and differentiation f the epithelia. Our data 
suggest that puberty hormones, directly or indirectly, con- 
trol the synthesis of HGF in the local mesenchyrne, and 
demonstrate hat this mesenchymal factor induces branch- 
ing of epithelial ducts. At a later stage of development, 
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pregnancy hormones appear to control the synthesis of 
NRG in the local mesenchyme, and we demonstrate that 
this mesenchymal factor induces lobulo-alveolar develop- 
ment and milk production of the mammary gland epithe- 
lium. Thus, the molecular nature of two sequentially ex- 
pressed factors has been elucidated, that control the 
postnatal development of the mammary gland. Many fac- 
tors have been tested for functional effects on mammary 
gland epithelium. HGF and NRG are the only known fac- 
tor that can induce branching and lobulo-alveolar mor- 
phogenesis in this system. Together with the high levels of 
HGF and NRG during puberty and pregnancy, respec- 
tively, and the tight regulation of gene expression in the 
local mesenchyme, this provides strong evidence for a cru- 
cial role of the two factors in morphogenesis and dif- 
ferentiation of the mammary gland. 
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